Creating a culture of shared data

Accelerating research to the bedside

Developing drugs for personalised medicine

Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression

The Innovative Medicines Initiative

Combination chemotherapy for multiple myeloma

Results of the AML 12 trial

Why we are not ready for personalised medicine

Genetically profiling entire populations, starting with Estonia

How does ancestry affect your health?

Neuroblastoma and cell communication networks

Personalised medicine differs from precision medicine